Articles by Natalie Dickmeyer - Pharmaceutical Executive

ADVERTISEMENT

Articles by Natalie Dickmeyer

Cancer: From Rut to Racetrack

We've heard the objective: to make most cancers a curable, chronic condition. But with soaring costs, demanding patients, crowded therapeutic competition, and new diagnostic reimbursement challenges ahead, can industry deliver?
Jul 1, 2011

The objective is to make most cancers a curable, chronic condition. But with soaring costs, crowded therapeutic competition, and new diagnostic reimbursement challenges ahead, can industry deliver?

ADVERTISEMENT

Click here